Diadema Partners »

Adma Biologics shares owned by Diadema Partners

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 200k 8.37

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Adma Biologics

BlackRock
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
Rubric Capital Management
Capital Research Global Investors
First Trust Advisors
Geode Capital Management
Caligan Partners
D. E. Shaw & Co
Dimensional Fund Advisors
Goldman Sachs Group
Nuveen
Duquesne Family Office
Morgan Stanley

View all funds holding Adma Biologics